Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

39.46
BATS BZX Real-Time Price
As of 12:14pm ET
 +0.31 / +0.79%
Today’s Change
37.24
Today|||52-Week Range
49.08
-2.21%
Year-to-Date
GSK Special Dividend: GSK will begin trading ex-dividend on 02/17/16 with a $1.2516 special dividend payable to shareholders of record as of 02/19/16.

Today’s Trading

Previous close39.15
Today’s open38.95
Day’s range38.91 - 39.48
Volume1,665,624
Average volume (3 months)3,856,901
Market cap$95.3B
Dividend yield6.06%
Data as of 12:14pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+10.02%
Earnings growth (next 5 years)+6.30%
Revenue growth (last year)-3.66%
P/E ratio9.7
Price/Sales2.70
Price/Book12.57

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.43-0.88%
BMYBristol-Myers Squibb+0.10+0.17%
SNYSanofi+0.17+0.44%
ABBVAbbVie-0.32-0.61%
Data as of 12:14pm ET, 02/12/2016

Financials

Next reporting dateApril 27, 2016
EPS forecast (this quarter)$0.59
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers